Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Gentle enough for newborns, safe for daily use, and tested by both pediatricians and dermatologists
At baseline for the two groups combined, mean age was 48 years
Tirzepatide: 20.2% in SURMOUNT-5 In the head-to-head SURMOUNT-5 trial, tirzepatide reached 20.2% average weight loss compared with 13.7% for semaglutide at 72 weeks
Now, oral GLP-1s for weight loss are available
,
Importantly, patients should be advised to be on the lookout for any mood or behavioural changes
US$ 27.51
US$ 22.10
US$ 29.44
US$ 24.98
